BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19114673)

  • 21. Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children.
    Chokephaibulkit K; Cressey TR; Capparelli E; Sirisanthana V; Muresan P; Hongsiriwon S; Ngampiyaskul C; Limwongse C; Wittawatmongkol O; Aurpibul L; Kabat B; Toye M; Smith ME; Eksaengsri A; McIntosh K; Yogev R;
    Antivir Ther; 2011; 16(8):1287-95. PubMed ID: 22155910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrapartum single-dose carbamazepine reduces nevirapine levels faster and may decrease resistance after a single dose of nevirapine for perinatal HIV prevention.
    Muro EP; Fillekes Q; Kisanga ER; L'homme R; Aitken SC; Mariki G; Van der Ven AJ; Dolmans W; Schuurman R; Walker AS; Gibb DM; Burger DM
    J Acquir Immune Defic Syndr; 2012 Mar; 59(3):266-73. PubMed ID: 22134145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.
    Cressey TR; Jourdain G; Lallemant MJ; Kunkeaw S; Jackson JB; Musoke P; Capparelli E; Mirochnick M
    J Acquir Immune Defic Syndr; 2005 Mar; 38(3):283-8. PubMed ID: 15735445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of life.
    Desmond AC; Moodley D; Conolly CA; Castel SA; Coovadia HM
    BMC Pediatr; 2015 Mar; 15():23. PubMed ID: 25885678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates.
    Cressey TR; Punyawudho B; Le Coeur S; Jourdain G; Saenjum C; Capparelli EV; Jittayanun K; Phanomcheong S; Luvira A; Borkird T; Puangsombat A; Aarons L; Sukrakanchana PO; Urien S; Lallemant M;
    J Acquir Immune Defic Syndr; 2017 Aug; 75(5):554-560. PubMed ID: 28489732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission.
    Jackson JB; Parsons T; Musoke P; Nakabiito C; Donnell D; Fleming T; Mirochnick M; Mofenson L; Fowler MG; Mmiro F; Guay L
    AIDS; 2006 Jan; 20(2):217-22. PubMed ID: 16511414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies to prevent mother-to-child transmission of HIV.
    McIntyre J
    Curr Opin Infect Dis; 2006 Feb; 19(1):33-8. PubMed ID: 16374215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiretroviral regimens in pregnancy and breast-feeding in Botswana.
    Shapiro RL; Hughes MD; Ogwu A; Kitch D; Lockman S; Moffat C; Makhema J; Moyo S; Thior I; McIntosh K; van Widenfelt E; Leidner J; Powis K; Asmelash A; Tumbare E; Zwerski S; Sharma U; Handelsman E; Mburu K; Jayeoba O; Moko E; Souda S; Lubega E; Akhtar M; Wester C; Tuomola R; Snowden W; Martinez-Tristani M; Mazhani L; Essex M
    N Engl J Med; 2010 Jun; 362(24):2282-94. PubMed ID: 20554983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F; Bequet L; Ekouevi DK; Viho I; Rouet F; Horo A; Sakarovitch C; Becquet R; Fassinou P; Dequae-Merchadou L; Welffens-Ekra C; Rouzioux C; Leroy V;
    AIDS; 2005 Feb; 19(3):309-18. PubMed ID: 15718842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions for preventing late postnatal mother-to-child transmission of HIV.
    Horvath T; Madi BC; Iuppa IM; Kennedy GE; Rutherford G; Read JS
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD006734. PubMed ID: 19160297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.
    Chasela CS; Hudgens MG; Jamieson DJ; Kayira D; Hosseinipour MC; Kourtis AP; Martinson F; Tegha G; Knight RJ; Ahmed YI; Kamwendo DD; Hoffman IF; Ellington SR; Kacheche Z; Soko A; Wiener JB; Fiscus SA; Kazembe P; Mofolo IA; Chigwenembe M; Sichali DS; van der Horst CM;
    N Engl J Med; 2010 Jun; 362(24):2271-81. PubMed ID: 20554982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral Drug Concentrations in Breastmilk, Maternal HIV Viral Load, and HIV Transmission to the Infant: Results From the BAN Study.
    Davis NL; Corbett A; Kaullen J; Nelson JAE; Chasela CS; Sichali D; Hudgens MG; Miller WC; Jamieson DJ; Kourtis AP
    J Acquir Immune Defic Syndr; 2019 Apr; 80(4):467-473. PubMed ID: 30570527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1.
    Mugabo P; Els I; Smith J; Rabie H; Smith P; Mirochnick M; Steyn W; Hall D; Madsen R; Cotton MF
    S Afr Med J; 2011 Sep; 101(9):655-8. PubMed ID: 21920159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the Kisumu Breastfeeding Study, Kenya: a clinical trial.
    Thomas TK; Masaba R; Borkowf CB; Ndivo R; Zeh C; Misore A; Otieno J; Jamieson D; Thigpen MC; Bulterys M; Slutsker L; De Cock KM; Amornkul PN; Greenberg AE; Fowler MG;
    PLoS Med; 2011 Mar; 8(3):e1001015. PubMed ID: 21468300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.
    Mandelbrot L; Landreau-Mascaro A; Rekacewicz C; Berrebi A; Bénifla JL; Burgard M; Lachassine E; Barret B; Chaix ML; Bongain A; Ciraru-Vigneron N; Crenn-Hébert C; Delfraissy JF; Rouzioux C; Mayaux MJ; Blanche S;
    JAMA; 2001 Apr; 285(16):2083-93. PubMed ID: 11311097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine.
    Giaquinto C; Rampon O; De Rossi A
    Clin Drug Investig; 2006; 26(11):611-27. PubMed ID: 17163296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.
    Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; John-Stewart GC
    AIDS; 2005 Sep; 19(13):1415-22. PubMed ID: 16103773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.